Albertson TM - Search Results

1

DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice.

Albertson TM, Ogawa M, Bugni JM, Hays LE, Chen Y, Wang Y, Treuting PM, Heddle JA, Goldsby RE, Preston BD. Albertson TM, et al. Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17101-4. doi: 10.1073/pnas.0907147106. Epub 2009 Sep 24. Proc Natl Acad Sci U S A. 2009. PMID: 19805137 Free PMC article.

2

DNA replication fidelity: proofreading in trans.

Albertson TM, Preston BD. Albertson TM, et al. Curr Biol. 2006 Mar 21;16(6):R209-11. doi: 10.1016/j.cub.2006.02.031. Curr Biol. 2006. PMID: 16546074 Free article.

3

Divergent cellular phenotypes of human and mouse cells lacking the Werner syndrome RecQ helicase.

Dhillon KK, Sidorova JM, Albertson TM, Anderson JB, Ladiges WC, Rabinovitch PS, Preston BD, Monnat RJ Jr. Dhillon KK, et al. Among authors: albertson tm. DNA Repair (Amst). 2010 Jan 2;9(1):11-22. doi: 10.1016/j.dnarep.2009.09.013. Epub 2009 Nov 5. DNA Repair (Amst). 2010. PMID: 19896421 Free PMC article.

4

Case series: acute tumor lysis syndrome in mutator mice with disseminated lymphoblastic lymphoma.

Treuting PM, Albertson TM, Preston BD. Treuting PM, et al. Among authors: albertson tm. Toxicol Pathol. 2010 Apr;38(3):476-85. doi: 10.1177/0192623310362249. Epub 2010 Feb 26. Toxicol Pathol. 2010. PMID: 20190201

5

DNA replication fidelity and cancer.

Preston BD, Albertson TM, Herr AJ. Preston BD, et al. Among authors: albertson tm. Semin Cancer Biol. 2010 Oct;20(5):281-93. doi: 10.1016/j.semcancer.2010.10.009. Epub 2010 Oct 15. Semin Cancer Biol. 2010. PMID: 20951805 Free PMC article. Review.

6

Bayesian dose escalation in oncology with sharing of information between patient populations.

Broglio KR, Sandalic L, Albertson T, Berry SM. Broglio KR, et al. Contemp Clin Trials. 2015 Sep;44:56-63. doi: 10.1016/j.cct.2015.07.003. Epub 2015 Jul 11. Contemp Clin Trials. 2015. PMID: 26173185

7

Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.

Abramson JS, McGree B, Noyes S, Plummer S, Wong C, Chen YB, Palmer E, Albertson T, Ferry JA, Arrillaga-Romany IC. Abramson JS, et al. N Engl J Med. 2017 Aug 24;377(8):783-784. doi: 10.1056/NEJMc1704610. N Engl J Med. 2017. PMID: 28834486 No abstract available.

8

A Bayesian adaptive phase 1 design to determine the optimal dose and schedule of an adoptive T-cell therapy in a mixed patient population.

Quintana M, Li DH, Albertson TM, Connor JT. Quintana M, et al. Among authors: albertson tm. Contemp Clin Trials. 2016 May;48:153-65. doi: 10.1016/j.cct.2016.04.004. Epub 2016 Apr 19. Contemp Clin Trials. 2016. PMID: 27109037 Clinical Trial.

9

Travel-Related Economic Burden of Chimeric Antigen Receptor T Cell Therapy Administration by Site of Care.

Snyder S, Albertson T, Garcia J, Gitlin M, Jun MP. Snyder S, et al. Adv Ther. 2021 Aug;38(8):4541-4555. doi: 10.1007/s12325-021-01839-y. Epub 2021 Jul 18. Adv Ther. 2021. PMID: 34279805 Free PMC article.

10

GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma.

Boldajipour B, Lee G, Albertson T. Boldajipour B, et al. N Engl J Med. 2023 Jun 15;388(24):2303. doi: 10.1056/NEJMc2305296. N Engl J Med. 2023. PMID: 37314724 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page